NCT03866460View on ClinicalTrials.gov

Determining Whether Intra-Arterial Carboplatin Causes Hearing Loss in Children

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

March 6, 2019

Primary Completion Date

November 4, 2024

Study Completion Date

November 4, 2024

Conditions
Intraocular RetinoblastomaHearing Loss
Interventions
DIAGNOSTIC_TEST

Distortion product otoacoustic emission measurement (DPOAE)

Hearing will be measured at baseline and 3-9 months after completion of treatment with IA carboplatin chemotherapy.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03866460 - Determining Whether Intra-Arterial Carboplatin Causes Hearing Loss in Children | Biotech Hunter | Biotech Hunter